Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Non-Current Debt: 2010-2025

Historic Non-Current Debt for Lifecore Biomedical (LFCR) over the last 15 years, with May 2025 value amounting to $121.2 million.

  • Lifecore Biomedical's Non-Current Debt rose 20.21% to $121.2 million in Q2 2025 from the same period last year, while for May 2025 it was $121.2 million, marking a year-over-year increase of 20.21%. This contributed to the annual value of $121.2 million for FY2025, which is 20.21% up from last year.
  • Per Lifecore Biomedical's latest filing, its Non-Current Debt stood at $121.2 million for FY2025, which was up 20.21% from $100.8 million recorded in FY2024.
  • In the past 5 years, Lifecore Biomedical's Non-Current Debt registered a high of $164.9 million during FY2021, and its lowest value of $84.3 million during FY2023.
  • Moreover, its 3-year median value for Non-Current Debt was $100.8 million (2024), whereas its average is $102.1 million.
  • Data for Lifecore Biomedical's Non-Current Debt shows a peak YoY surged of 62.68% (in 2021) over the last 5 years.
  • Lifecore Biomedical's Non-Current Debt (Yearly) stood at $164.9 million in 2021, then reached $84.3 million in 2023, then increased by 19.66% to $100.8 million in 2024, then climbed by 20.21% to $121.2 million in 2025.